Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

被引：0

作者：

Zhenxu Xiao

Xue Wu

Wanqing Wu

Jingwei Yi

Xiaoniu Liang

Saineng Ding

Li Zheng

Jianfeng Luo

Hongchen Gu

Qianhua Zhao

Hong Xu

Ding Ding

机构：

[1] Fudan University,Institute of Neurology, Huashan Hospital

[2] National Clinical Research Center for Aging and Medicine,School of Biomedical Engineering

[3] Huashan Hospital,Department of Biostatistics, School of Public Health

[4] Fudan University,Key Lab of Public Health Safety of the Ministry of Education

[5] Shanghai Jiao Tong University,undefined

[6] Fudan University,undefined

[7] Fudan University,undefined

来源：

Alzheimer's Research & Therapy | / 13卷

关键词：

Plasma p-tau181; Simoa; Cognitive domain; CDR; Alzheimer’s disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease
Llibre-Guerra, Jorge J.
Iaccarino, Leonardo
Coble, Dean
Edwards, Lauren
Li, Yan
Mcdade, Eric
Strom, Amelia
Gordon, Brian
Mundada, Nidhi
Schindler, Suzanne E.
Tsoy, Elena
Ma, Yinjiao
Lu, Ruijin
Fagan, Anne M.
Benzinger, Tammie L. S.
Soleimani-Meigooni, David
Aschenbrenner, Andrew J.
Miller, Zachary
Wang, Guoqiao
Kramer, Joel H.
Hassenstab, Jason
Rosen, Howard J.
Morris, John C.
Miller, Bruce L.
Xiong, Chengjie
Perrin, Richard J.
Allegri, Ricardo
Chrem, Patricio
Surace, Ezequiel
Berman, Sarah B.
Chhatwal, Jasmeer
Masters, Colin L.
Farlow, Martin R.
Jucker, Mathias
Levin, Johannes
Fox, Nick C.
Day, Gregory
Gorno-Tempini, Maria Luisa
Boxer, Adam L.
La Joie, Renaud
Rabinovici, Gil D.
Bateman, Randall
BRAIN COMMUNICATIONS, 2023, 5 (06)
[22] Plasma cortisol is associated with cerebral hypometabolism across the Alzheimer's disease spectrum
Wirth, Miranka
Lange, Catharina
Huijbers, Willem
NEUROBIOLOGY OF AGING, 2019, 84 : 80 - 89
[23] Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
Tatsuoka, Curtis
Tseng, Huiyun
Jaeger, Judith
Varadi, Ferenc
Smith, Mark A.
Yamada, Tomoko
Smyth, Kathleen A.
Lerner, Alan J.
ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (02):
[24] Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease
Lim, Yen Ying
Maruff, Paul
Kaneko, Naoki
Doecke, James
Fowler, Christopher
Villemagne, Victor L.
Kato, Takashi
Rowe, Christopher C.
Arahata, Yutaka
Iwamoto, Shinichi
Ito, Kengo
Tanaka, Koichi
Yanagisawa, Katsuhiko
Masters, Colin L.
Nakamura, Akinori
JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (03) : 1057 - 1065
[25] Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance
Lee, J. -H.
Jeong, S. -K.
Kim, B. C.
Park, K. W.
Dash, A.
ACTA NEUROLOGICA SCANDINAVICA, 2015, 131 (05): : 259 - 267
[26] Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance
Plagman, Alexandra
Hoscheidt, Siobhan
McLimans, Kelsey E.
Klinedinst, Brandon
Pappas, Colleen
Anantharam, Vellareddy
Kanthasamy, Anumantha
Willette, Auriel A.
NEUROBIOLOGY OF AGING, 2019, 76 : 201 - 207
[27] Clinical evaluation as a biomarker for Alzheimer's disease
Cummings, Jeffrey L.
JOURNAL OF ALZHEIMERS DISEASE, 2005, 8 (04) : 327 - 337
[28] Plasma and Brain Fatty Acid Profiles in Mild Cognitive Impairment and Alzheimer's Disease
Cunnane, Stephen C.
Schneider, Julie A.
Tangney, Christine
Tremblay-Mercier, Jennifer
Fortier, Melanie
Bennett, David A.
Morris, Martha Clare
JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (03) : 691 - 697
[29] Association Between White Matter Disease and Cognitive Function is Independent of Alzheimer's Disease Biomarker Profile
Lam, Sharon
Lipton, Richard
Harvey, Danielle
Zammit, Andrea
Ezzati, Ali
NEUROLOGY, 2021, 96 (15)
[30] Plasma β-amyloid:: Biomarker for Alzheimer's disease or epiphenomenon?
Durham, R
Lockwood, P
Ewy, W
Raby, C
Evans, L
Emmerling, M
NEUROBIOLOGY OF AGING, 2002, 23 (01) : S384 - S385

← 1 2 3 4 5 →